75419-36-2 Usage
Description
S-11-P, also known as 3-Amino-2,3-dideoxy-D-myo-inositol, is a semisynthetic aminoglycoside compound derived from the natural product myo-inositol. It possesses unique structural features and properties that make it a promising candidate for various applications in different industries.
Uses
Used in Pharmaceutical Industry:
S-11-P is used as a semisynthetic aminoglycoside antibacterial agent for the development of new antibiotics. It exhibits potent antibacterial activity against a wide range of Gram-negative and Gram-positive bacteria, including drug-resistant strains. Its unique structure allows for the design of novel derivatives with improved pharmacological properties and reduced side effects.
Used in Drug Delivery Systems:
S-11-P can be incorporated into drug delivery systems to enhance the efficacy and safety of existing antibiotics. Various nanocarriers, such as liposomes, polymeric nanoparticles, and metal-organic frameworks, can be used to encapsulate and deliver S-11-P, improving its solubility, bioavailability, and targeting to specific bacterial cells.
Used in Agricultural Industry:
S-11-P can be utilized as a bioactive compound in the development of new antimicrobial agents for agricultural applications. It can be used to control plant pathogens and pests, reducing the need for chemical pesticides and promoting sustainable agriculture practices.
Check Digit Verification of cas no
The CAS Registry Mumber 75419-36-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,4,1 and 9 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 75419-36:
(7*7)+(6*5)+(5*4)+(4*1)+(3*9)+(2*3)+(1*6)=142
142 % 10 = 2
So 75419-36-2 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO4/c7-2-1-3(8)5(10)6(11)4(2)9/h2-6,8-11H,1,7H2/t2-,3+,4+,5-,6-/m0/s1
75419-36-2Relevant articles and documents
Isolation of nabscessin C from nocardia abscessus IFM 10029T and A study on biosynthetic pathway for nabscessins
Hara, Shoko,Hara, Yasumasa,Arai, Midori A.,Kusuya, Yoko,Takahashi, Hiroki,Yaguchi, Takashi,Ishibashi, Masami
, p. 976 - 982 (2018/10/15)
A new aminocyclitol derivative, designated nabscessin C (1), was isolated from Nocardia abscessus IFM 10029T. Nabcessin C is an isomer of nabscessins A (2) and B (3) with different positioning of the acyl group. Absolute configuration of nabscessin A was determined by conversion into the 2-deoxy-scyllo-inosamine pentaacetyl derivative (4) by hydrolysis and acetylation of 2. The biosynthetic pathway of nabscessins is proposed based on gene expression analysis.
Biosynthesis of aminoglycoside antibiotics: Cloning, expression and characterisation of an aminotransferase involved in the pathway to 2-deoxystreptamine
Huang, Fanglu,Li, Yanyan,Yu, Jinquan,Spencer, Jonathan B.
, p. 2860 - 2861 (2007/10/03)
The gene btrR from Bacillus circulans has been cloned and expressed and shown to produce a protein which catalyses the transamination of 2-deoxy-scyllo-inosose to give 2-deoxy-scyllo-inosamine, an intermediate in the biosynthesis of 2-deoxystreptamine.
Chemical synthesis of 3-amino-2,3-dideoxy-D-inositol (an intermediate in the biosynthesis of 2-deoxystreptamine) and its D-epi stereoisomers
Baer, Hans H.,Siemsen, Lisa,Astles, David J.
, p. 247 - 255 (2007/10/02)
-
